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INTRODUCTION 
Continuous function of the central nervous 
system is vitally important to the organism as a 
whole and such function is very strongly dependent upon 
a continuous and adequate blood supply. Interruption 
of cerebral blood flow for a few seconds leads to un-
consciousness and for a few minutes may lead to irrever-
sible changes in the brain. Thus, the physiologic and 
pharamacologic regulation of cerebral blood flm" (or CBF 
as it is frequently referred to) becomes especially 
important. A discussion of the methods of study is 
helpful in understanding current concepts of this 
regulation. 
METHODS OF S;l'UDY 
Anatomical problems include the great complexity 
of the anatomy of cerebral circulation and the extensive 
communications between cerebral and extracerebral cir-
cUlation. This is especially a problem in the usual 
laboratory animals. 
Measurement of flow to anyone of the major cere-
bral vessels is subject to such limitations as being 
representative of an indeterminant portion of the brain 
or being contaminated by extracerebral flow. In all 
animals the anastamoses with the vertebral plexus of 
veins and other veins make measurement of CBF on the 
venous side almost impossible. However, this has been 
done on the isolated head (1), but this could hardly be 
considered physiologic. 
In man the blood of the superior bulb of the in-
ternal jugular vein makes a relatively uncontaminated 
and representati.ve specimen of cerebral venous blood 
(2) (3). This has allowed many of these anatomi.cal 
problems to become minimized in the development of 
quantitative methods for measuring CBF (4) (5) (6). 
The various techniques of study must be evaluated 
in the light of these anatomical problems and in their 




Direct observation of intracranial or related 
vessels may utilize gross, microscopic or photographic 
methods. By inserting a cranial window (7) (8), obser-
vations can be made under more physiologic conditions. 
A comparable technique more applicable to man is fundus-
copic examination of the retinal vessels which are 
anatomical extensions of the cerebral vessels and react 
similar to them in many instances (9)(10)(11). It must 
be remembered that this provides only qualitative infor-
mation on the behavior of the cerebral blood vessels and 
not the CBF which is also dependent upon other factors. 
Observation of the superficial vessels of the brain or 
retina is limited to the relatively large vessels whose 
responses may differ qualitatively and quantitatively 
from those of the small intracerebral arterioles which 
are most important in determining CBF. 
Thermoelectric devices may be used to detect changes 
in CBF (12)(13)(14). The various types of thermo-
stromuhrs which permit measurement in intact vessels 
are not very reliable. However, thermocouples inserted 
into the bloodstream of the otherwise intact vessel are 
more satisfactory. Both the heated and the cooled types 
are used. In the former the thermocouple is cooled and 
in the latter it is warmed by the flow of blood, the 
-3-
c. 
change in temperature resulting in a change in electri-
cal current varying proportionately to the rate of blood 
flow. 
A Gibbs thermoelectric flow recorder (15), i.e. 
in the form of a needle, has been used for studies in 
the internal jugular vein in man. rrhis needle and its 
modifications have been inserted directly into brain 
tissue and have been found capable of indicating direc-
tional changes in blood flow. Its advantages include 
its simplicity, convenience, and ability to follow 
continuously the change in blood flow. Disadvantages 
include: does not provide reliable quantitative data 
when used in vessels subject to the previously mentioned 
anatomical li!'!itations, temperature changes in the blood 
or immediate environment, clot formation around the 
needle, change in vessel diameter, change in relation 
of the stream of blood to the position of the needle 
and inflammatory changes of the tissues. 
Various flow meter techniques: There are a number 
of instruments, which when inserted in series with a 
vascular channel, can measure with reasonable accuracy 
the rate of blood flow through that vessel (12). 
This is essentially a glass tube of known cross-sectional 
area, which when inserted between the severed ends of a 
I 
-'+-
blood vessel, permitted the measurement of the blood 
flow velocity by quantitating the movement of an air 
bubble trapped Hi thin it. From the veloc i ty, the 
volume of blood flow could be calculated. By placing 
the instrument in a single, isolated, common arterial 
pathway to the brain after surgical occlusion of all 
other possible arterial channels and anastamoses with 
the extracerebral circulation, it was possible to ex-
clude many of the anatomical problems mentioned above. 
In most laboratory animals this involves very extensive 
surgery and alteration of the normal physiology, but in 
monkeys this method is more applicable. 
D. Artificial perfusion of the brain has been used to 
study alterations in CEF (16)(17)(18). A major advantage 
of this method is in being able to control certain fac-
tors involved in blood flow, for example blood pressure, 
the fluctuation of which is a frequently encountered 
variable. By perfusing at a constant arterial blood 
pressure this variable can be excluded. However, again 
the disadvantages of major surgery and anesthesia re-
quired to isolate the cerebral circulation are encountered. 
1i:. The difference in oxygen conte~ts or saturations 
between arterial and cerebral venous blood is ?irectly 
proportional to the oxygen consumption and inversely 
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proportional to the CBF. 'l'hus, an importmt require-
ment is that the venous blood be representative of the 
brain as a whole and especially uncontaminated by blood 
from extracerebral sources. Such blood is easily ob-
tained from man from the superior bulb of the internal 
jugular vein (19)(2)(3). ~fuen cerebral metabolic rate 
remains constant, a change in the arteriovenous oxygen 
difference reliably indicates the direction and degree 
of change in CBF. ~~en this latter condition is fulfilled, 
this method, because of its simplicity, is especially 
useful in man. 
F. Because the normal adult craniovertebral cavity 
is essentially a ~igid, indistensible container com-
pletely filled with~incompressable material, any in-
• t 
crease in volume o:f one of i-t:c contents must be at the 
" 
expens~ of another. \-,n tHis basis, Ferris has applied 
the. principles of venous occlusion plethysmography to 
the measurement of intracranial blood flow in man. 
Unfortunately he assumed that the inflation of a cuff 
around the neck to a pressure of 60 to 80 mm Eg. would 
occlude the venous outflow from the cranium and thus 
the rate of displacement of spinal fluid through a 
needle in the lumbar subarachnoid space would equal 
the rate of continued arterial blood flow into the 
-6-
cranium. Such an assumption cannot be made, however, 
This method completely ignores the numerous pathways 
other than the internal jugular veins through which venous 
blood may leave the cr~~ial cavity. Consequently, this 
method is of very little value in determining CBF. 
Since its introduction by Kety and Schmidt approx-
imately fifteen years ago (20)(6), the nitrous oxide 
technique has become the standard method for studying 
the cerebral blood flow. This method is based on the 
Fick Principle (21). This principle represents a prac-
tical application of the law of conservation of matter 
to the problem of blood flow measurements. This might 
be explained as: blood flow to any organ or to the 
body as a whole may be obtained as the ratio between 
the uptake of inert gas per unit time and the arterio-
venous inert gas difference across the organ in question. 
Kety and Schmidt applied this method to the cerebral 
circulation in man. Since then it has been applied 
to various other organs and animals with similarly 
satisfactory results. 
The procedure may be described briefly as follows: 
During a suitable period of inhalation of a constant 
concentration of gas (in this example nitrous oxide), 
blood samples are taken from a reripheral artery--
-7-
assumed to be representative of the cerebral arteries--
and from the main venous drainage from the brain, the 
internal jugular vein. After a suitable experimental 
period, which allows approximately complete saturation 
of all cerebral tissues, (frequently ten minutes), it 
is possible to estimate indirectly the gas uptake per 
unit weight of brain fromfue venous concentration. 
Since the nitrous oxide content of the brain cannot be 
determined directly, the brain nitrous oxide concentra-
ti6n at ten minutes is estimated from the tenth minute 
value of the cerebral venous nitrous oxide cnncentration 
to which it is assumed to be equal. This assumption is 
based on evidence that by the tenth minute brain and 
mixed cerebral venous blood have achieved approximate 
equilibrium and the brainjblood partition coefficient 
is normally 1.0 (22). 
Since the concentration rather than the total con-
tent of nitrous oxide is employed in the calculation, 
the derived values of blood flow represent the average 
blood flow rate per uhi te mass of brain taken as a v~hole 
and not that of the total brain. The unit mass of brain 
used is usually 100 gram. 
Because some of the basic assumptions are only 
approximately correct, it becomes very important that 
-8-
H. 
the validity of the method has been clearly demon-
strated by Kety and Schmidt (23)(24). These authors 
found close agreement between this method and the direct 
blood flow method in experiments covering a large span 
of perfusion values, i.e., 17 to 76 cC/IOOgm/min. 
Since its accuracy has been accepted as being 
reasonably reliable, several variations of the original 
method have appeared. For example, Scheinberg and 
Stead (25) have simplified the method and reduced the 
amount of blood sampling necessary, but only at the 
expense of decreased accuracy. Kennedy and his co-
workers (26) have adapted it to children by decreasing 
the volume of the blood samples. Presision has been 
increased by increasing the number of blood samples, 
the use of Kr85 (a Beta-emitting isotope of krypton) 
and by sampling from both internal jugular veins (26)(27). 
Lewis and associates, using the V-emitting Kr 79 as the 
inert gas, made a more fundamental modification. By 
direct and continuous external measurement of the amount 
of inert gas in the whole brain and simultaneous blood 
sampling, they made it possible to calculate the total 
cerebral blood flow and to follow any fairly rapid 
changes in this flow (28)(29). 
A non-diffusible tracer substance which remains in 
the circulatory system when injected into a cerebral 
-9-
1. 
artery, is diluted by the DBF in passing through the 
cerebral vascular bed. The degree of dilution, as 
determined from the quantity or rate of injection of 
the tracer material and again the difference in arterial 
and representative cerebral venous blood was interpreted 
by Gibbs et.al (14) to be a measure of CBF. However, 
as demonstrated by Shenkin eta al (3), dye when injected 
into a single cerebral artery is not uniformly mixed and 
thus the blood drained in one internal jugular vein is 
then not representative of that of the brain as a whole. 
This might be overcome by bilateral intracarotid injec-
tion or bilateral internal jugular vein sampling, or 
perhaps both are required. The end result of this 
complexity is that the method is not often used. 
Radioactive inert gas technique for the quantitative 
dertermination of regional cerebral blood flow: 
As previously mentiOned, the rate of blood flow to any 
given area of the brain may vary independent of that 
to another area of the brain (30)(31)(32). Only one of 
the above mentioned methods provides data on the blood 
flow of individual regions of the brain. Thermocouples 
inserted in the various area of the brain may indicate 
local changes in blood flow, but they are subject to 
numerous limitations and yeild only qualitative infor-
-10-
mation rather than quantitative. 
A method has been described by Kety and his assoc-
iates which measures simultaneously and quantitatively 
the blood flow in as many as twenty-eight structures 
of the brain (33)(30)(31). The method is basedm the 
principle that the uptake of an inert radioactive gas 
by a tissue is a function of the preceding history of 
the arterial concentration of the gas, the partition 
coefficient of the gas between the tissue and blood, 
the time, and the blood flOIr? of that tissue. During 
intravenous infusion of a solution of the radioactive 
gas, arterial concentration is continuously monitored 
by a scintillation counter. Then, at a specific recorded 
time the head is removed, frozen and the concentrations 
of the gas in the various cerebral structures are deter-
mined by a radioautographic technique. Thus with these 
data, using the measured solubilities of the gas in 
blood and brain tissue, the blood flow in the various 
areas can be calculated. This method gives reliable 
results but obviously is useful only on laboratory 
animals (30) (31)(32). 
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NomlAL REGULATION OF THE CEREBRAL CIRCULATION 
There are numerous revie~ of the physiology of 
the cerebral circulation (34)(35)(36)(37)(38)(13)(39). 
Drugs usually alter the cerebral circulation by in-
fluencing the physiological mechanisms normally regulating 
it. It should be remembered that the brain is the organ 
which receives highest priority in the body's effort to 
preserve its most vital organs from circulatory 
insufficiency. In order to accomplish this, the regula-
tion of the CBF must be unique. 
As in all vascular beds, the blood flo\<! is ultimately 
determined by two major hemodynamic factors: (1) the net 
pressure gradient across the vascular bed, (2) the total 
resistance to blood flow in the vascular channels. 
These two factors, in turn, are determined by the numer-
ous forces that alter, regulate or contribute to them. 
It is by altering one or both of these major factors 
that physiologic and/or pharmacologic changes in the 
CBF are accomplished. 
A. Cerebral blood pressure gradient: 
Cerebral venous pressure is very low in relation 
to usual cerebral arterial pressure and is therefore 
gen~rally of very little i~portance in determining 
CBF. However, in instances where it is greatly 
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altered, it may assume a more significant role. 
For example, a marked fall in cerebral venous 
pressure may be an important mechanism in main-
tenance of CBF under gravitational stress (40). 
Likewise, a marked elevation of cerebral venous 
pressure might also be expected to influence CBF. 
However, this has not been clearly demonstrated (41). 
Huch more important in determining CBF is the 
mean arterial blood pressure. Earlier it was assumed 
that the CBF passively followed the mean arterial 
pressure (42)(13)(39). Later studies carried out 
in man showed that intrinsic regulation of the 
cerebral vascular resistance also occurs. This 
tends to keep the CBF within Certain normal limjts 
despite changeS in blood pressure and may alter it 
indepentent of blood pressure. Fog (43) had earlier 
reported that pial vessels of animals under direct 
observation constricted in response to an increase 
in arterial blood pressure and dilated in response 
to a fall in arterial blood pressure. Likewise, in 
man the CBF does not increase in essential or 
drug-induced hypertension (44)(45)(46)(47) because 
of this increase in cerebral vascular resistance 
in these instances. Also consistant with Fog's 
-13-
observation is the finding that cerebral vascular 
resistance also buffered the eff~cts of arterial 
hypotension (48)(49)(50). 
In normotensive subjects it was also found 
that reducing the mean arterial blood pressure to 
approximately 30 mm Hg., or one-third the normal 
level resulted in clinical signs and symptoms of 
cerebral ischemia. (51). This was accomplished by 
use of hexamethonium and/or tilting the subjects. 
It was also noted that subjects with malignant 
hypertension or p6stural hypotension did not re-
duce their cerebral vascular resistance as effectively 
and thus developed signs and symptoms of cerebral 
ischemia with a smaller decrease in me5n arterial 
blood pressure. In all cases the evidence of 
cerebral ischemia appeared when the CBF fell to a 
mean of 31.5 ml per 100 grams per minute. This is 
approximetely sixty percent of the control level. 
It is also postulated (52) that in secondary shock 
and other hypotensive states resulting in uncon-
sciousness that the mean arterial blood pressure 
falls below the limits of compensation by changes 
in cerebral vascular resistance. 
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B. Cerebral vascular resistance: 
Under physiological conditions CBF is regulated 
chiefly by changes in the cerebral vascular resis-
tance. For quantitative determinations this is 
defined as the ratio of cerebral blood pressure 
gradient to blood flow.(6). Actually it is made 
up of a number of factors which tend to impede the 
flow of blood through the cerebral vessels. These 
factors will be discussed individually below: 
1. Blood viscosity: 
Blood viscosity varies mainly with red blood 
cell concentration but also with marked changes 
in the plasma protiens or other cell concentra~ 
tj_ons. An increase in RBC concentration leads to 
an increase in resistance and a decreased concen~ 
tration to a decreased resistance to flow. The 
increase in resistance becomes more marked as the 
upper limits of normal red cell concentration 
are exceeded (53). Thus in polycythemia vera we 
see anextremely low cerebral blood flow and 
a high cerebrovascular resistance (35). Likewise 
there is an increased CBF seen with anemia (54)(55). 
2. Intracranial pressure: 
The cerebral vessels are partially exposed 
to the direct pressure of the cerebrospinal fluid. 
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As the cerebrospinal pressure increases, one 
would expect the size of the vessel lumen to 
decrease and fuus the resistance to blood flow 
to increase. Likewise, as the cerebrospinal 
fluid pressure decreases, one might expect to 
see a certain amount of expansion of the blood 
vessel wall and an increase in blood flow. 
Observations made to date do not seem to be so 
clear-cut (56)(57)(58)(59). However, observations 
made on normal subjects would seem to indicate 
that a reduction in intracranial pressure, as 
occurs on assupmtion of the erect position (25) 
or under the influence of positive radial 
acceleration (60), tends to increase the CBF 
by lowering the cerebrovascular resistance. 
Because most of the inconsistant observations and 
reports were not made on normal subjects, this 
author tends to give them less emphasis. 
3. Size and tone of cerebral vessels: 
It is largely through the adjustment of 
the diameter or tone of the cerebral ves2els and 
the consequent altsration of cerebrovascular 
resistance that the normal regulation and remark-
able hemeostasis of the cerebral circulation 
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is accomplished. It is also through their effect 
on the cerebrovascular tone that most drugs and 
diseases cause their alteration in the CBF. 
Anatotlical nar owing of the vessel lumen and 
therefore increased resistance are seen in the 
two most comm0n vascular diseases: arteriosclerosis 
and hypertension (61)(11)(62)(63)(64). 
Alterations in CBF may be brought ~bout by 
(1) direct changes in the vessels themselves 
as above or (2) by alterations of some of the 
following control mechanisms of the cerebro-
vascular tone: 
a. Neurogenic control: 
Because of the minute size and great num-
ber of vessels and nerve pathways and many 
other technical difficulties involved, this 
area of study is very difficult. It would 
seem to this author that the following con-
elusions may be valid: (1) Neural vasomotor 
mechanisms in the cerebral vasculature do 
exist but their role in the resulation of 
cerebrovascular tone is not obvious at this 
time. (2) Evidence seems to suggest that 
there is no resting neurogenic vasoconstriction 
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tone mediated through the cervical synpathetics. 
(3) It also seems unlikely that there is any 
resting neural vasodilator tone. (4) The 
cerebral vasomotor reflexes are not integrated 
into the general circulatory reflexes such as 
those from the carotid and aortic pressorecep-
tors. (5) When neurogenic vasomotor effects 
are demonstrated, they are of small magnitude. 
These conclusions were suggested by the follow-
ing works, (65)(66)(67)(66)(68)(69)(70)(14)(71) 
(72)(39)(73)(74)(75)(76)(77), and do not seem 
to be of major importance. 
b. Chemical control: 
The only major changes in CBF that have 
been experimentally induced are those caused by 
chemicals. The endogenous chemicals that are 
most prominently involved in the normal regul-
ation of cerebrovascular tone will be considered 
at this time. 
The respiratory gasses, i.e. oxygen and 
carbon dioxide, are the most potent agents of 
this type. An increase in the blood carbon 
dioxide causes a marked vasodilatation and 
increase in the CBF, as if to get rid of the 
-18-
excess waste product. A decreased blood car-
bon dioxide level, as in hyperventilation, causes 
a vasoconstriction and a decrease in CBF 
An increase in blood oxygen concentration 
causes a vasoconstriction and a decrease in CBF. 
A decrease in blood oxygen concentration causes 
a vasodilatation and thus an increased CBF 
tending to compensate for the oxygen lack. 
(78)(79)(80) . 
Thus in general we have carbon dioxide 
acting as a vasodilator and oxygen acting as 
a vasoconstrictor. 1~en the forces of the two 
are opposing one another at usual physiologic 
concentrations, carbon dioxide seems to be the 
stronger of the two (35)(13)(39). However, 
if the hypoxemia is greet enough, it will over-
come the vasoconstrictor effect of low carbon 
dioxide (81)(78)(82). 
Acids and bases have been reported to 
cause cerebral vasodilatation and vasoconstric-
tion, respectively (17)(13)(39)(8). Despite 
the markedly lowered blood carbon dioxide which 
occurs in diabetic coma, there is a reduced 
-19-
cerebrovascular resistance and increased CBF. 
This would suggest that the severe acidosis 
existing in this condition might have more 
influence on the cerebral vessels than the 
reduced carbon dioxide. Thus while in usual 
physiologic ranges we find carbon dioxide a 
more potent agent than changes in pH or oxygen 
concentratjon, when the latter two are far 
enough from the normal range, especially when 
they are attempting to dilate vessels, they 
become more potent. 
These observations can be integrated if 
one notes that the normal chemical products or 
consequences of increased tissue metabolism, 
for exafuple, increased carbon dioxide, reduced 
oxygen, and alse,.. perhaps, lOv-Jered pH, tend to 
produce cerebral vasodilatation; and since 
changes in the opposite direction which would 
accompany decreased cerebral metabolic activity 
cause vasoconstriction, it has been suggested 
that CBF may be adjusted via such ch2mical means 
to local metabolic activity. 
This mechanism would tend to maintain chem-
ical hemeostasis which is what is required and 
-20-
observed in most physiologic regulatory sys-
tems (83)(olJ\.84)(13)(14). That such a 
homeostasis mechanism exists is supported by 
the good correlations between the levels of 
CBF and oxygen consumption in man (35) and 
in the monkey (85), and by the parallel in-
crease in both during metrozol convulsions in 
the monkey (85). Other findings supporting 
this theory are close correlations between 
CBF and cerebral activity seen in the rabbit 
(86) and cat (87)(88). 
In man, 101.<; metabolic rates and low CBF 
have been observed in various pathological 
states of depressed mental function (35), 
but normal variations of mental activity, 
for example, normal sleep (89) or performance 
of mental arithmetic (90) seem to produce no 
detectable change in CBF. It should be empha-
sized that this does not mean that such changes 
do not take place. One explanation might be 
that these changes are too subtle to be de-
tected with present methods and equipment. 
Another explanation might be that such changes 
take place only locally in the specific area of 
-21-
of the brain that is involved in the greater 
activity while the rest of the brain has a 
decreased rate of metabolism and oxygen con-
sumption, thus giving no net change in o~Jgen 
consumption and CBF as measured for the whole 
brain by most methods. 
Then to the first theory of CBF regulation 
locally by metabolic chemicals, we add secondly 
that the mean arterial blood pressure tends to 
be maintained constant at the brain because of 
nervous vasomotor reflexes of the baroreceptor 
type. The cerebral vessels seem to be indepen~ 
dent of these neural vasomotor mechanisms. It 
is this independence which allows the blood 
flow to the brain to be maintained in certain 
ciEcumstances at the expense of other tissues. 
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THE EFFEcrl'S OF DRUGS ON 1'HE CEREBRAL CIRCULATION 
In spite of the remarkable ability of the CBF to 
maintain hemeostasis, its limits of compensation nat-
urally can be exceeded. In such instances it may be 
desireable to administer drugs in an effort to restore 
the abnormal CEF to within normal limits. A brief dis-
cussion of the many drugs used for this purpose follows. 
In this discussion these drugs will be grouped as they 
usually are in pharmacology rather than by any system 
regarding only their use for the effect on the cEF. 
In deciding how much time to devote to each drug the 
factors considered were: its importance in the general 
prac~ic2 of medicine today, its usefulness in altering 
CEF, and finally how much research has been d~ne on the 
effects of this drug on the CEF. 
A. The respiratory gases are given further consideration: 
1. Carbon dioxide: 
The effects of hyperventilation betray the 
fact that the carbon dioxide normally present in 
blood exerts a continuously tonic vasodilator 
action on the cerebral vessels (91)(92)(4) 
The mechanism or method by which carbon 
dioxide alters the tone of the cerebral vessels 
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is not known for certain but two suggestions 
are offered. One is that it is a local axon 
reflex which has not been demonstrated thus far. 
A more likely explanation is that it is the direct 
action of carbon dioxide upon the smooth muscle 
of the vessel wall as it diffuses through this 
wall from the surrounding tissues. One might 
consicLer the finding that oxygen diffuses through 
the walls of relatively large pial veins to be in 
support of this theory (39)(96). 
Some of the quantitative studies of the 
effects of carbon dioxide are as follows: 
Kety and Schmidt originally noted that the CBF 
of young and old subjects alike increased approx-
imately seventy-five percent during the inhalation 
of five to seven percent carbon dioxide (78)(E2)(91). 
~hat may be more exact observations report that 
inhalation of five percent carbon dioxide increases 
CBF approximately fifty percent (78)(97)(64), 
whereas inhalation of seven percent carbon dioxide, 
the concentration with approximately maximal effects 
on pulmonary ventilation and blood pressure (98), 
more than doubles the blood flow (78)(99)(95) 
(97)(64). One cannot say whether seven percent 
also produces maximal cerebral circulatory changes 
because reliable oomparable data from man with 
higher concentrations is not available. 
Regarding lower concentrations, it was found 
that inhalation of two and one-half percent carbon 
dioxide does not alter the CBF. However, 3.5% 
CO
2 
produced a slight but significant increase in 
CBF of ten percent (97). 
Quantitative studies of hypocapnea in man 
(91)(92)(4)(94)(78)(99)(95) show a greater 
degree of cerebral vasoconstriction than has been 
obtained by any other method, i.e. 60% of the 
control flow achieved by lowering blood carbon 
dioxide from 45 to 26 mm mercury by active or 
passive hyperventilation. This low level of CBF 
approaches that at which syncope occurs (51) as 
expected evidence of cerebral ischemia was present. 
The response of the CBF to alterations of arterial 
carbon dioxide were prompt, almost immediate, the 
latency obtained is largely attributable to the 
inaccuracies of the technique (99)(95). 
The threshold of the cerebral circulatory 
response to increased carbon dioxide concentrations 
in the inspired air is reduced when combined with 
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low blood oxygen concentration (100)(97), i.e., 
the CBF which is already increased by hypoxemia 
is percentage-wise less increased by an increase 
in inspired carbon dioxide than it normally is by 
carbon dioxide alone. Apparently the cerebral 
vasodilatation already produced by hypoxemia 
(74)(61)(10)(78)(102)(13)(39)(8) represents 
a con tributary part of that which would result from 
a raised carbon dioxide tension alone and tends to 
combat the vasoconstriction effect of a reduced 
carbon dioxide tension. One might even carry this 
further and expect to find the exact point of 
lowered oxygen tension at which the effects of 
carbon dioxide are negligible. This point, of 
course, must be exceeded if we are to reach the 
point where the oxygen concentration becomes far 
enough from the physio16gic range that the vaso-
dilatation power of hypoxemia exeeds the con-
strictive power of hypocapnea. Quantitative 
studies in the dog by Noell and Schnei er (82) 
indeed show that this point is at a cerebral venous 
oxygen tension of approximately nineteen mm. mercury. 
Observation of similar phenomenon in man is also 
reported (81). 
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In the clinical conditions of resporatory 
arrest (103) or rebreathill.g (101) in which again 
combined hypoxemia and hypercapnea are encountered, 
this action allows at least a temporary protective 
mechanism for the central nervous system. In 
these instances the administration of additional 
carbon dioxide with the intention of improving 
cerebral circulation would ~robably be of very 
little help and indeed raises the immediate dan-
ger of increasing the carbon dioxide level to a 
depressant level. It has been difinitely shown 
that carbon dioxide becomes less ~fective as its 
blood tension deviates further from the normal 
physiologic range (82). However, in conditions 
of hypoxemia not complicated by carbon dioxide 
retention, but rather by hypocapnea secondary to 
hyperventilation, the administration of carbon 
dioxide provides effective aid against the cere-
bral effects of oxygen lack (101). 
The action of carbon dioxide on the cerebral 
circulation is altered very little, if at all, by 
elevated blood oxygen tensions (104). This illus-
trates what a relatively weak cerebral vasocon-
strictor hyperoxemia is (54)(105)(78)(79)(102) 
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(106)(80)(8). Thus the combination of high 
oxygen ahd high carbon dioxide concentrations in 
inspired air which is so frequently employed 
clinically is a very helpful combination, i.e., 
the patient receives a~most the same degree of 
augmentation of the CBF as with pure carbon di-
oxide---plus the higher oxygen concentration. 
As mentioned previously, acidosis causes 
cerebral vasodilatation (17)(107)(13)(39)(8), 
and when severe enough, this acidosis may override 
the effect of a reduced blood carbon dioxide in 
diabetic coma (108). On the other hand, in meta-
bolic alkalosis the cerebral vascular responses 
to carbon dioxide are not decreased (109). 
The~e is much speculation concerning the loss 
of vascular wall elasticity associated with advan-
cing a~e (61)(91)(110)(63)(64) and/or cerebral 
vascular disease (61)(91)(110)(62)(64). 
Schieve and Wilson (64) came to the conclusions 
that cerebral vascular reactivity to the inhalation 
of five and seven percent carbon dioxide decreases 
gradually with age, falls markedly with cerebral 
vascular disease and that it could be used clin-
ically to distinguish between senile dementia 
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arising from pr~mary brain degeneration and that 
secondary to cerebral vascular disease. However, 
further investigation has tended to indicate that 
although the degree of reactivity is somewhat re-
duced, especially when the disease is organic and 
associated with old age, this change in reactivity 
does not appear to be sufficiently pronounced or 
uniform enough to be used as a reliable test for 
organic cerebrovascular disease. (91)(78)(63) 
Study has also been make on the effect of 
carbon dioxide on local cerebral circulation (72) 
(111)(70)(14)(71). Kety and associates (33) 
(30)(31) show that blood flow to all parts of 
the brain is increased by carbon dioxide, but the 
increases were not uniform (112). The changes 
were absolutely and relatively greater in gray 
matter than in white. 
As for the mechanism of action of carbon 
dioxide on the CBF, it seems to be almost entirely 
through its effect on cerebrovascular resistance 
(61)(91)(78)(62)(97). Of the various pre-
viously mentioned factors which determjne resis-
tance, only two are greatly altered. First, the 
cerebrovascular tone is marke'ly decreased by 
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carbon dioxide. Active dilatation of the pial 
vessels has been directly visualized "Ii thout any 
associated drop in arterial blood pressure (113) 
(8), thus the resultant increase in CBF. The 
second factor which is altered, namely the intra-
cranial pressure, is increase by the vasodilatation 
and resultant increased blood volume, content and 
flow to the brain (114)(115)(116)(9)(117). This 
increase in intracranial pressure would tend to 
increase rather than lower cerebrovascular resis-
tance, but its effect is a minor one. The mechan-
ism of this dilatation is probably by direct action 
of carbon dioxide on the smooth muscle of vessel 
walls (39)(96) as mentioned earlier. 
The increase in CBF caused by increased car-
bon dioxide is associated with an increase in the 
mean arterial blood pressure of man and laboratory 
animals (61)(78)(62)(98)(118)(74)(111). This 
would also contribute to the rise in CBF but this 
does not seem to be responsible for most of this 
increase (91)(78)(39). This increase arterial 
blood pressure is due to a stimulation of the vaso-
motor center by carbon dioxide and a resultant 
vasoconstriction in the extranial circulation. 
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There is no increase in cardiac output. The cor-
onary circulation does not appear to be affected 
by carbon dioxide (14)(119)(103)(120)(102)(121) 
(122)(123)(14)(124)(78)(123)(125). A reduction 
in blood carbon dioxide concentration causes the 
opposite effect (119)(120)(102)(121). 
Useful applications of the effects of carbon 
dioxide might include: 
(a) It is useful to aid recovery from general 
anesthesia because it stimulates pulmonary ventil-
ation, thus increasing the rate of elimination of 
volatile anesthetics, and because of the greater CBF 
there is a faster removal of the anesthetic agent 
from the central nervous system. 
(b) In circulatory collapse or secondary shock 
carbon dioxide may be useful. By dilating cerebral 
vessels and constricting the extracranial vascular 
bed, except for the coronary vessels, (125), the 
cardiac output is redistributed to favor the brain 
at the expense of less vital tissues (119)(103)(120) 
(l02)(121)(123){14)(124). It might also counteract 
the hypocapnea secondary to the hyperventilation 
frequently associated with these conditions and 
thus prevent the expected cerebrovascular constriction. 
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(c) It is probably because of the above mentioned 
redistribution of cardiac output that it gives a 
greater tolerance to positive radial acceleration 
and thus delays the loss of consciousness (126) 
( 127 )( 128 ) • 
(d) Carbon di~xide has been reported to inhibit 
petit mal seizures (129), but is should be noted 
that the etiology of these seizures does not in-
volve the cerebral circulation (130) (93). The 
mechanism of action in this example is probably 
related to the effects of carbon dioxide on the 
electrical activity of the brain which will be 
discussed below. (81)(121) 
(e) The therapeutic use of carbon dioxide in 
chronic cerebral vascular insufficiency is ques-
tionable. Three percent carbon dioxide is useful 
in counteractin the mental effects of anoxemia 
(131) and the increased cerebral venous oxygen 
saturation is secondary to the augmentation of 
the CBF by carbon dioxide. However, the improve-
ment in the mental and electrical activities can-
not entirely be attributed to better oxygenation 
~f the brain. Gibbs reported mental and electro-
encephalogr~phic abnormalities in subjects 
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inspiring gas mixtures free of carbon dioxide and 
low in oxygen concentration when the cerebr2-1 
venous oxygen concentration was at a level during 
which these functions had been normal when the 
subjects were breathing carbon dioxide-enriched 
low oxygen mixtures (101). It is felt that the 
anoxemia and its secondary hyperventilation lowered 
the carbon dioxide concentration of the blood and 
brain below the optimum concentration of carbon 
dioxide which is necessary to maintain normal 
cortical electrical activity and mental function 
(81)(121). 
2. Oxygen: 
Quantitative studies demonstrate that the 
vasoconstrictive effects of higher cerebral arter-
ial oxygen concentration are less potent than the 
vasodilatation caused by hypoxemia. The breathing 
of eighty-five to one hundred percent oxygen con-
centration causes only a mild decrease in CBF of 
approximately twelve to fifteen percent (54)(78) 
(79). At onc atmosphere breathing, fifty or 
eighty IJercent oxygen concentration has a negligible 
effect on CBF. In contrast, reducing the arterial 
oxygen concentration by breathing ten percent 
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oxygen causes an increase in the CBF of almost 
fifty percent and a marked decrease in cerebro-
vascular resistance (78). This homeostatic type 
of response by the cerebral vasculature to hypox-
emia allows a greater decrease in the arterial 
oxygen concentration before the critical concen-
tration is reached in the tissue and venous blood. 
'l'his is illustrated by the fact that the oxygen 
concentration of internal jugular venous blood, 
which reflects the concentration of cerebral 
tissue, falls more slowly than arterial oxygen 
concentration upon ::he inhalation of low oxygen 
mixtures (121). 
The approximate critical range of cerebral 
venous oxygen concentration below which conscious-
ness is lost is between twenty-four and thirty 
percent (132). This corresponds to an oxygen 
tension of approximately fifteen to twenty mm Hg. 
There is no detectable 6hange in cerebral oxygen 
consumption as the subject becomes unconscious (78). 
This h~,lds true for oxygen concen tra tions as low 
a6 eight and ten percent (80). This does not 
necessarily mean that they do not exist, as these 
changes may be too subtle for present methods to 
detect. 
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The chan~es in cerebral circulation caused 
by hypoxemia are not uniform for all areas of the 
brain (1120(133). The circulation to the gray 
matter, which is genera~ly greater than that of 
white matter, has a greater absolute and relative 
increase. The alterations are not even uniform 
for all areD.S of gray matter. 
It has been suggested that the mental changes 
of hypoxemia may be due to the reflex hyperpnea and 
hypocapnea, i.e. the same mechanism responsible 
for the mental sy~ptoms seen without lowered cere-
bral oxygen utilization during hypocapnea produced 
by hyperventilation (78). It is interesting that 
at approximately the same critically low level of 
cerebral venous oxygen both consciousness and the 
normal electroencephalographic pattern are lost 
( 132 )( 121) . 
The mechanism by which oxygen concentration 
causes its effect on cerebral vessels is ot very 
well understood at this time. 
Genen~lized convulsions are frequently seen 
during prolonged inhalation of oxygen at pressures 
greater than one atmosphere (134)(135). Because 
changes in CBF and carbon dioxide retention. 
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secondary to oxygen saturation of venous blood 
have been excluded as etiological "'" . .lact:ors, it is 
suggested that there may be acirect toxic 
effect of high oxygen tensions on the enzyme sys-
tems of the central nervous system (134)(135)(79). 
When premature infa.nts are subjected to pro-
longed periods of high oxygen concentration inhala-
tion, a~enomemon called retrolental fibroplasia 
takes place (136)(137). The high oxygen tension 
apparently allows obliteration of part of the vas-
cular bed which is needed when the oxygen concen-
tration of the blood is allowed to return to normal. 
The administration of oxygen to patients with 
chronic pulmonary disease is well known as a source 
of problems (106)(138)(139)(140)(141). The para-
doxical response frequently seen here is the apnea 
caused as oxygen administration removes the hypoxic 
stimulation of a respiratory center no longer sen-
sitive to change in the markedly abnormal carbon 
dioxide concentration. 
3. Miscellaneous agents which alter respiratory gas 
transport qr function: 
a. Acetazoleamide (Diamox) if given in large enough 
do doses to inhibit nearly all carbonic anhydrase 
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activity (i.e., 10-50 mg/Kg.) results in an 
increase in CBF which persists over an hour 
after injection (142). Although ~he arterial 
carbon dioxide content is decreased by the 
hyperventilation, there is an increase in the 
venous and tissue carbon dioxide concentrations 
because of the carbonic anhydrase inhibition. 
b. Carbon monoxide interferes with blood transfer 
of oxygen and thus produces vascular changes 
similar to hypoxemia. Breathing concentrations 
as low as 0.2 to 0.3% cause up to forty to 
eighty percent dilatation of pial arteries (143). 
c. The increased volume of the brain subsequent to 
cyanide adminstration suggests cerebral vaso-
dilatation. Its cytotoxic anoxic mechanism 
causes changes similar to those of hypoxemic 
anoxia (lL~4). 
B. Acids, Alkalis, Electrolytes, Inorganic Ions and Fluids: 
Acids and alkalis have been discussed previously 
and their effect is not especially impressive. However, 
certain electrolytes, inorganic ions and fluid agents 
cause their effect because they are acids or alkalis. 
It has been suggested that the potassium ion may be 
a cerebral vasodilator (13)(85). Calcium ion is 
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reported to have no effect (121). Barium ion, as 
five percent barium chloride, is a potent vasocon-
strictor of all vessels. However, lower concentrations 
have very little effect (145). 
In general, it does not appear that these agents 
cause much effect on CBF. The major exception being 
the decrease in cerebrospinal fluid seen after admin-
istration of hypertonic solutions, urea, or after 
diuresis. The major mechanism operating is the de-
crease in cerebrospinal fluid pressure and the second-
ary decrease in cerebrovascular resistance. There 
is also some alteration in the cerebral hemodynamics 
due to the change in blood viscosity. 
C. Drugs acting on the central nervous system: 
1. Central nervous system depressants: 
a. General anesthetics: ~hen administered to the 
point of respiratory depression, all anesthetic 
agents cause cerebral vasodilatation and in-
creased blood flow secondary to hypoxia and 
carbon dioxide retention. 
The nitrous oxide method can only be used 
in the presence of volatile agents if the radio-
active krypton modification (146)(99)(95)(147) 
is employed because of the interference in blood 
nitrous oxide determinations. 
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Diethyl ether has repeatedly been demon-
strated to have a specific cerebrovascular 
dilating effect, (148)(149)C150)(39)(115)(114) 
(14)(72)(71), and an extracrania1 vasocon-
striction similar to carbon dioxide. Then when 
the medullary centers become depressed, the 
extracranial vasoconstriction relaxes. The CBF, 
h01tJever , continues to be augmented. 
Most experiment~ evidence seems to suggest 
that in general volatile anesthetics tend to 
dilate cerebral blood vessels. (13)(14)(39) 
(149)(152)(151)(113)(153)(43) It must be rem-
embered that much of the information available, 
especially that obtained from animals, was ob-
tained while the subject was under some type 
of anesthesia. 
Many reports of the effects of barbituates 
on CBF are available and they can be taken to 
be somewhat representative of the general anes-
thetics. The one exception is ether. Any major 
effect that these agents do have is probable 
secondary to their effects on blood pressure, 
cerebral metabolic rate, and the respiratory 
gas tensions of the blood. 
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The one effect demonstrated to be due to 
the barbituate is decreased metabolism rate and 
thus decreased oxygen requirement (154)(155)(156) 
(157)(64)(158)(159)(115). Because of the chem-
ical regulatory mechanisms described earlier, 
there is then a decreased cerebral blood flow. 
The greatest reduction of blood flow takes place 
in the primary sensory areas of the cerebral 
cortex. Thus the net result is that the differ-
ences in blood flow among the various cortical 
areas, so prominent during consciousness, are 
eliminated (30)(31). 
b. Local anesthetics: No effect could be demon-
strated by systemic administration of 750 mgm 
porcaine or novocaine to normal subjects (160). 
However, there have been reports of rapid clear-
ing of neurological abnormalities secondary to 
cerebral gas embolism after the intravenous 
administration of procaine(161). 
c. Narcotics: These drugs cause no significant 
direct ~ffect on CBF. Their effects when they 
do occur are due to influence on respiratory rate 
and the secondary carbon dioxide retention. The 
resultant cerebrovascular dilatation is probably 
responsible for the increase in cerebrospinal 
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fluid pressure seen with these drugs (115). 
d. Ethyl alcohol: Venous concentrations of 
200 mgm% have no effect on cerebral metabolic 
rate, vascular resistance or blood flow (162) 
(163)(164)(165). ll'lith higher concentrations, 
an increase in CBF has been demonstrated, but 
whether alcohol is directly responsible is yet 
to be proven (162)(163). 
Methyl alcohol, however, causes a decrease 
in both cerebral blood flow and metabclicrate 
(163)(166). 
e. Hypnotics, sedatives, analgesics and anti-
convulsants: With one exception, there haa been 
no significant effect demonstrated by these 
~gents. Unlike adults, it has been reported that 
cerebral blood flow was significantly reduced 
~ epileptic children. Effective therapy 
with d~phenylhydantoin restored these values to 
normal. The mechanis~ is not understood (167) 
(92 )(93). 
2. Central nervous system excitants: 
a. Convulsant drugs: Only with large enough doses 
of these drugs to cause convulsions is the cBF 
and oxygen consumption increased. Following the 
seizure the CEF, metabolic rate, and functional 
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activity were markedly reduced. When no con-. 
vulsion occurred, the same or even larger dos-
age failed to produce an increas in the CBF 
(74)(85). Thus the alteration in CBF is due 
to the same chemical phenomenon that normally 
accompanies changes in metabolic rate (168)(88). 
However, the compensation that occurs is in-
adequate and cerebral oxygen concentration may 
fall to remarkably low levels during convul-
sions (35)(168). Thus the therapeutic use of 
analeptic drugs to stimulate a depressed nervous 
system can be hazardous. 
b. Xanthines: Intravenous admjnstration of ther-
apeutic doses of caffeine sodium benzoate, 
theophylline and aminophylline has been shown 
to cause a decrease in CBF of up to twenty-five 
percent (169)(170). This effect has been em-
ployed successfully to treat hypertensive head-
aches (171). The conclusion was made that this 
was due to relief of vascular distention. 
Moyer and co-workers (172) have come to 
the conclusion that these drugs arrest Cheyne-
Stokes respiration by direct stimulation of the 
respiratory center. However, alternatives in-
clude such suggestions as relative ischemia, 
-42-
anoxia and/or carbon dioxide accumulation in 
the respiratory center. 
3. Psychotropic drugs: (There are so many new drugs 
of this type that only a representative few will 
be mentioned) 
a. Psychotomimetic drugs: 
Mescaline, a drug which~oduces psychic 
aberrations and visual hallucinations was shown 
to increase CBF and metabolic rate (173)(174) 
D-lysergic acid (LSD-25), a partially 
synthesized derivative of ergot, produces sim-
ilar effects in extremely minute doses (176) 
(177)(178). Studies on man failed to reveal 
detectable changes in CBF or metatolism. How-
ever, doses twenty times those used in man caused 
an increase in CBF ±n the isolated ~at head (179). 
b. Psychotherapeutic drugs: 
In this group of drugs there has been no 
demonstration of change in metabolic rate or CBF. 
Summarizing the psychotropic drugs B.S a 
group, it would seem that their psychological 
and mental changes are to some extent similar 
to those of the barbituates OF of schizophrenia, 
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i.e., without any change in cerebral meta-
bolic rate or blood flow that can be detected 
by present methods. 
D. Autonomic Drugs: 
1. Sympathomimetic Drugs: 
a. Epinephrine: Less than pressor does of epin-
ephrine have little or no effect on cerebral 
circulation and metabolism (46). However, when 
pressor doses are used, the CBF increases in 
proportion to the rise in blood pressure because 
the cerebrovascular resistance remains unchanged 
(169)(45). The expected vasoconstriction re-
sponse to the blood pressure increase is prob-
ably neutralized by the increased metabolic rate 
and its associated vasocilatatory influence (43)(45). 
b. L-Norepinephrine (Levophed): In the normal state 
the vasoconstriction influence of. this drug is 
neutralized to some extent by the pressoreceptor 
reflexes (180)(45)(46). Because the cerebral 
vessels are not under the influence of these 
reflexes, they are constricted more than the 
rest cr the vascular bed (13)(39). The result 
is a decrease in CBF while the metabolic rate 
remains Unchanged. 
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In hypotension due to secondary shock 
the mechanism is less understood but it causes 
an increase in blood flow and oxygen tension 
in the brain (18). Some of this effect is due 
to the rise in cardiac output produced by this 
drug in certain stages of hemorrhagic shock (182) 
(181)(183). 
c. Aramine: Acts like L-Norepinephrine (184). 
d.Wyamine: Actions resemble Epinephrine (185). 
e. Amphetamine: This drug causes an increase in 
blood pressure but does not alter CBF or cere-
bral metabolic rate. 
2. Parasympathomimetic Drugs: 
Although the cerebral circulation is without 
any significant parasympathetic nervous control, 
the choline esters are capable of dilating cere-
bral vessels as they do other vascular beds, but 
their effect apparently is only transiet in nature 
and of minimal importance (74)(111)(14)(13)(85). 
Because this vasodilatation results from their 
direct action and is not a simpJe response to the 
associated hypotension they cause, there is an 
actual increase in CBF. Pilocarpine and the cholin-
esterase inhibitors do not seem to cause any 
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important change either (13)(14)(85). Their 
greatest influence on the CBF is secondary to 
their systemic effects, especially those on 
the mean arterial blood pressure. 
3. Autonomic Blocking Agents: 
a. Adrenergic blocking agents: The natural ergot 
alkaloids exert no consistant action on the cere-
bral vessels. They may dilate in small doses 
and constrict in larfe doses, but CBF usually 
follows the change in systemic blood pressure 
and cerebral metabolic rate is unchanged (85)(74). 
The findings of vfolff ana his associa [-es suggest 
that migraine headache results from the disten-
tion of the branches of the external carotid 
artery which are all extracerebral in man. They 
feel that ergotamine relieves the headache by 
constricting them and reducing the pulsations 
within them (186). 
The dihydrogenated ergot alkaloids cause 
a cerebrovascular relaxation but this is prob, 
ably a non-specific response to the hypotension 
they produce and is probably mediated by the 
chemical mechanisms of cerebral herr@©stasis 
(187)(188)(189)(190)(191)(28)(49)(50). 
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It is unlikely that the imidazoline 
derivatives have any significant effect on the 
cerebral circulation (192)(193)(194). 
Dibenzyline produces its effect only by 
its influence on the arterial blood pressure (195)(190). 
b. Drugs which block post-ganglionic cholinergic 
nervous function show no reliable evidence that 
they have a significant influence on CBF. 
c. Ganglionic blocking agents exert their effect 
only by the hypotension they produce (196). 
d. Nicotine and related drugs cause in increase in 
cerebral metabolic rate and CBF up to 30% when 
large enough doses were used (197). This may 
be due to stimulation of the carotid and aortic 
chemoreceptors (198), the release of epinephrine 
(198), or to direct stir:mlation of the central 
nervous system. 
~. Miscellaneous Vasodilatory Drugs: 
This group has in common the ability to produce 
anteriolar and/or capillary dilatation of the cerebral 
and extracerebral circulation by direct action on the 
vessel walls. 
1. Histomine causes cerebral vasodilatation in men and 
animals but because of its secondary hypotension 
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caused by a similar systemic effect, it does not 
always increase CBF (11+) (199) (169). Because its 
action is of transient nature, it is of little value 
in therapy of cerebrovascular insufficiency. 
2. Nitrites cause a marked but transient cerebral vaso-
dilatation and increased CBF (74)(169)(111). With 
~rolonged administration the hypotension finally 
overcomes the cerebral vasodilatation and CBF is 
decreased (Ill). 
3. Papaverine does not cause much change in the CBF 
because again there is an associated hypotension 
\ 200 ) (201) (202) . 
4. Nicotinic acid has no significant effect on CBF, 
vascular resistance or oxygen consumption (203)(204). 
F. Miscellaneous Antihypertensive Drugs: 
Included in this group are (1) the rauwolfia 
alkaloids, (2) veratrum alkaloids, and (3) hydralozine. 
These drugs fail to produce any direct effect on the 
CBF and their only influence is by decreasing the 
systemic blood pressure (205)(206)(207)(208)(209). 
G. Hormones and Related Drugs: 
1. Thyroid Hormone: The cerebral circulatory changes 
associated with altered thyroid function parallel 
those occuring in cardiac output (210)(211) and 
2. 
in blood flow to most other organs and tissues. 
However, the metabolic rate of the brain is un-
changed so this cannot be used to explain these 
changes. There is no evidence of a direct action 
on CBF by thyroid hormone but there is also no 
other explanation (212)(210)(213)(214)(215)(216). 
Insulin: Insulin administration even in dosage 
adequate to produce coma and depress the cerebral 
metabolic rate have no effect on the CBF (217). 
Insulin deficiency, however, may produce changes 
but these are dependent on the disturbances in 
acid-base balance or carbon dioxide tension. 
3. The adrenal medullary hormones have been discussed 
previously. 
4. AC'I'H ahd the adrenocortical steroids: Prolonged 
daily administration of these drugs increases mean 
arterial blood pressure and cerebrovascular resis-
tance proportionately, and no change in CBF or 
cerebral metabolic rate was detected. W'hen the 
drugs were discontinued the functions returned to 
normal (218)(219). 
5; Gonadal steroids and related compounds have no 
clearly understood role in regulation of CBF. 
6. The anterior pituitary hormones li~ewise have no 
clearly demonstrated effect on CBF. 
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7. The posterior pituitary hormones have minimal 
influence on the CBF and this is mostly depend-
ent on their alteration of systemic blood 
pressure (47). 
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SUJVlMARY AND CONCLUSION 
Because of importance of cerebral blood flow to 
the living organism, it also becomes important to under-
stand how this flow is maintained and altered by physiology 
and rharmacology. A discussion of the methods of stydying 
this cerebral blood flow regulation is presented init-
ially in order that current concepts might be better 
uncerstood. As these concepts are reviewed, the most 
remarkable observation is the great resistance of the 
cerebrB,l blood flow to change. There are two major fac-
tors operating in this resistance. First, pressoreceptor 
reflexes, including those with receptors in the internal 
carotid artery, a ~ajor source of supply to the brain, 
operate to maintain a more or less constant blood pres-
sure head for the cerebral circulation without involving 
the cerebral vessels in the adjustments necessary to 
accomplish this. Secondly, cerebrovascular resistance 
is altered by chemical products of metabolism in a man-
ner serving to maintain hemeostasis. The end result is 
a remarkable stable blood supply to the brain which is 
equally resistant to therapeutic efforts to change. 
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